UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applying sensitivity analyses to overall survival in cancer clinical trials

Journal of clinical oncology, 2010-07, Vol.28 (19), p.e323; author reply e324-e323

Wolff, Steven N

2010

Volltextzugriff (PDF)

Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource

Journal of health care for the poor and underserved, 2010-02, Vol.21 (1 Suppl), p.38-50

2010

Volltextzugriff (PDF)

High-dose etoposide: from phase I to a component of curative therapy

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5310-5312

2008

Volltextzugriff (PDF)

High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2240-2243

2008

Volltextzugriff (PDF)

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations

Journal of oncology practice, 2013-11, Vol.9 (6), p.267-276

2013

Volltextzugriff (PDF)

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review

Biology of blood and marrow transplantation, 2011, Vol.17 (1), p.20-47.e30

2011

Volltextzugriff (PDF)

Sickle Cell Trait ‐ Biochemical and Clinical Consequences

The FASEB journal, 2007-04, Vol.21 (5), p.A92-A92

Wolff, Steven N.

2007

Volltextzugriff (PDF)

Racial differences in the pattern of hematologic toxicity in the treatment of colorectal cancer

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.679-679

2012

Volltextzugriff (PDF)

Psychosocial outcomes in cancer survivors treated at a comprehensive cancer center or a minority-serving institution

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20523-e20523

2013

Volltextzugriff (PDF)

Somatic mutation spectrum of non-small cell lung cancers (NSCLCs) from African Americans (AAs)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6038-6038

2012

Volltextzugriff (PDF)

Abstract A45: Molecular targets in early detection and differentiation of inflammatory bowel disease-associated colon-rectal-anal cancer disparities

Cancer epidemiology, biomarkers & prevention, 2011-09, Vol.20 (10_Supplement), p.A45-A45

2011

Volltextzugriff (PDF)

Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow

The New England journal of medicine, 1984-06, Vol.310 (24), p.1557-1561

1984

Volltextzugriff (PDF)

Hematopoietic cell transplant from volunteer unrelated or partially matched related donors: recent developments

Current opinion in organ transplantation, 2000-12, Vol.5 (4), p.372-381

Wolff, Steven N.

2000

Volltextzugriff (PDF)

Effects of high-dose cytarabine

Clinical pharmacology and therapeutics, 1982-05, Vol.31 (5), p.669-674

1982

Volltextzugriff (PDF)

Oxidative Stress and NF- κ B Activation: Correlation in Patients Following Allogeneic Bone Marrow Transplantation

Antioxidants & redox signaling, 2000-03, Vol.2 (1), p.93-102

2000

Volltextzugriff (PDF)

Intensified Preparative Regimens and Allogeneic Transplantation in Refractory or Relapsed Intermediate and High Grade Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 2001-04, Vol.41 (3-4), p.343-352

2001

Volltextzugriff (PDF)

Long‐term survival of patients with acute myeloid leukemia

Cancer, 1997-12, Vol.80 (S11), p.2186-2190

1997

Volltextzugriff (PDF)

Is Total Body Irradiation a Necessary Component of Preparative Therapy for Autologous Transplantation in non-Hodgkin's Lymphoma

Leukemia & lymphoma, 2001-03, Vol.41 (1-2), p.97-103

2001

Volltextzugriff (PDF)

Age and Cytogenetics as Predictors of Event Free Survival in Patients with Acute Non-Lymphocytic Leukemia Receiving High Dose Cytosine Arabinoside and Daunorubicin as Consolidation Chemotherapy

Leukemia & lymphoma, 2001, Vol.42 (5), p.913-922

2001

Volltextzugriff (PDF)

High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies

Seminars in oncology, 1990-02, Vol.17 (1 Suppl 3), p.2

1990

Volltextzugriff (PDF)

Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

Leukemia & lymphoma, 1999-09, Vol.35 (1-2), p.91-98

1999

Volltextzugriff (PDF)

A brief‐duration combination chemotherapy for elderly patients with poor‐prognosis non‐Hodgkin's lymphoma

Cancer, 1991-03, Vol.67 (6), p.1487-1492

1991

Volltextzugriff (PDF)

The Burden of Cancer Survivorship: A Pandemic of Treatment Success

Handbook of Cancer Survivorship, 2007, p.7-18

2007

Volltextzugriff (PDF)

The Author’s Reply

American journal of clinical pathology, 1984-01, Vol.81 (1), p.144-145

Wolff, Steven N.

1984

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(54)
Humans
(49)
Adult
(23)
Female
(23)
Male
(20)
Middle Aged
(20)
Oncology
(19)
Aged
(15)
Combined Modality Therapy
(11)
Hematology
(11)
Adolescent
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Dose-Response Relationship, Drug
(7)
Neoplasms - Therapy
(6)
Prognosis
(6)
Treatment Outcome
(6)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(5)
Cohort Studies
(5)
Etoposide - Administration & Dosage
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Applying sensitivity analyses to overall survival in cancer clinical trials

Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource

High-dose etoposide: from phase I to a component of curative therapy

High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review

Sickle Cell Trait ‐ Biochemical and Clinical Consequences

Racial differences in the pattern of hematologic toxicity in the treatment of colorectal cancer

Psychosocial outcomes in cancer survivors treated at a comprehensive cancer center or a minority-serving institution

Somatic mutation spectrum of non-small cell lung cancers (NSCLCs) from African Americans (AAs)

Abstract A45: Molecular targets in early detection and differentiation of inflammatory bowel disease-associated colon-rectal-anal cancer disparities

Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Hematopoietic cell transplant from volunteer unrelated or partially matched related donors: recent developments

Effects of high-dose cytarabine

Oxidative Stress and NF- κ B Activation: Correlation in Patients Following Allogeneic Bone Marrow Transplantation

Intensified Preparative Regimens and Allogeneic Transplantation in Refractory or Relapsed Intermediate and High Grade Non-Hodgkin's Lymphoma

Long‐term survival of patients with acute myeloid leukemia

Is Total Body Irradiation a Necessary Component of Preparative Therapy for Autologous Transplantation in non-Hodgkin's Lymphoma

Age and Cytogenetics as Predictors of Event Free Survival in Patients with Acute Non-Lymphocytic Leukemia Receiving High Dose Cytosine Arabinoside and Daunorubicin as Consolidation Chemotherapy

High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies

Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

A brief‐duration combination chemotherapy for elderly patients with poor‐prognosis non‐Hodgkin's lymphoma

The Burden of Cancer Survivorship: A Pandemic of Treatment Success

The Author’s Reply

Aktive Filter

Suchergebnisse filtern